AN2 Therapeutics, Inc. - COM (ANTX)

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
13.5M
Holdings value Q3 2024
$14.5M
Value change Q3 2024
-$16.3M
Grand Portfolio weight change Q3 2024
0%
Number of holders
31
Number of buys Q3 2024
15
Number of sells Q3 2024
-29
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 13.5M $14.5M -$16.3M $1.07 31
2024 Q2 19.4M $41.7M -$1.46M $2.15 45
2024 Q1 18.7M $60.9M -$18M $3.25 54
2023 Q4 20.4M $418M +$9.59M $20.49 51
2023 Q3 19.9M $320M +$133M $16.08 37
2023 Q2 11.7M $99.9M +$18.1M $8.50 30
2023 Q1 9.6M $94.8M -$1.57M $9.87 37
2022 Q4 9.76M $93M -$3.68M $9.53 35
2022 Q3 9.5M $165M +$1.94M $17.38 35
2022 Q2 9.39M $72.4M +$2.2M $7.75 32
2022 Q1 8.95M $134M +$134M $15.07 18